Company · CIK 1623613
Mylan II B.V.
| CIK | 1623613 (SEC EDGAR) |
|---|---|
| Industry (SIC) | 2834 — Pharmaceutical Preparations |
| Incorporated in | P7 |
| Business address | United Kingdom |
| Listed | no ticker on SEC record today |
| First annual or quarterly report | 2015-05-08 |
Offerings
4 registrations| Registration | Label and status | First filed | Last event | Filings |
|---|---|---|---|---|
| 333-287087-02 | 2025-05-08 | 2026-06-15 | 3 | |
| 333-264760-02 | 2022-05-06 | 2022-05-06 | 1 | |
| 333-206913 | 2015-09-14 | 2015-09-14 | 1 | |
| 333-202345 | 2015-02-27 | 2015-02-27 | 1 |
Filings
12| Filed | Filing | Registration | Accession |
|---|---|---|---|
| 2026-06-15 | 424B5Shelf takedown | 333-287087-02 | 0001140361-26-025215 |
| 2026-06-12 | 424B5Shelf takedown | 333-287087-02 | 0001140361-26-024994 |
| 2025-05-08 | S-3ASRShelf registered | 333-287087-02 | 0001140361-25-017967 |
| 2022-05-06 | S-3ASRShelf registered | 333-264760-02 | 0001193125-22-143719 |
| 2021-09-28 | EFFECTDeclared effective | 333-259463-02 | 9999999995-21-003684 |
| 2018-12-11 | EFFECTDeclared effective | 333-228332-01 | 9999999995-18-003099 |
| 2017-01-03 | EFFECTDeclared effective | 333-214870 | 9999999995-17-000016 |
| 2016-06-16 | EFFECTDeclared effective | 333-210696 | 9999999995-16-004916 |
| 2015-09-14 | S-3ASRShelf registered | 333-206913 | 0001193125-15-319027 |
| 2015-09-10 | EFFECTDeclared effective | 333-203873 | 9999999995-15-002476 |
| 2015-02-27 | S-3ASRShelf registered | 333-202345 | 0001193125-15-069190 |
| 2014-12-23 | EFFECTDeclared effective | 333-199861 | 9999999995-14-003797 |